NI
GYRE icon

Numeric Investors’s Gyre Therapeutics GYRE Stock Holding History

Numeric Investors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-21
Closed -$80K – 827
2014
Q1 		$80K Buy
21
+1
+5% +$3.7K ﹤0.01% 759
2013
Q4 		$66K Sell
20
-63
-76% -$248K ﹤0.01% 757
2013
Q3 		$346K Buy
83
+35
+73% +$141K 0.01% 643
2013
Q2 		$162K Buy
+48
New +$183K ﹤0.01% 734

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Numeric Investors's GYRE Position: Q2 2014 in Review

Numeric Investors sold out of Gyre Therapeutics (GYRE) in Q2 2014, closing a stake of 21 shares — an estimated $80K sold.

Numeric Investors first reported a position in GYRE in Q2 2013 and held it in 4 quarters. The position peaked at $346K in Q3 2013. 63 funds tracked by Wall St. Rank hold GYRE as of Q2 2014.

  • Numeric Investors reported no remaining Gyre Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Numeric Investors sold 21 Gyre Therapeutics shares in Q2 2014, an estimated $80K.
  • Numeric Investors first reported a position in Gyre Therapeutics in Q2 2013 and held it in 4 quarters.
  • Numeric Investors's Gyre Therapeutics position peaked at $346K in Q3 2013.
  • 63 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2014.

Based on Numeric Investors's 13F filing for Q2 2014, filed 11 Aug 2014.